Alpha Medical LegitScript and Accreditation Status: Is Alpha Medical Legit?

At a glance
- LegitScript status / Not found on LegitScript certified telehealth operator list (as of July 2025)
- BBB rating / Not BBB accredited; complaint volume includes billing and cancellation disputes
- Services offered / Primary care, GLP-1 weight management, mental health, birth control
- Payment model / Insurance accepted plus cash-pay subscription
- Prescriber type / Nurse practitioners and physicians (state-dependent)
- Pharmacy fulfillment / Partners with third-party pharmacies; compounded GLP-1 availability varies
- FDA-approved GLP-1 drugs offered / Semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound) where in-stock
- Key risk flag / No publicly verifiable URAC or ACHC telehealth accreditation found
- State availability / Operates in most U.S. States; check individual state page for coverage
- Patient review average / Mixed; billing and prescription-delay complaints are the most cited issues
What Is Alpha Medical and How Does It Work?
Alpha Medical is a U.S.-based telehealth company that connects patients with licensed clinicians for primary care visits, GLP-1 weight-management prescriptions, mental health support, and contraception management. Patients complete an online intake, meet asynchronously or synchronously with a clinician, and receive prescriptions sent to a partnered pharmacy.
The company accepts major insurance plans in many states, which distinguishes it from pure cash-pay competitors. Cash-pay subscription tiers are also available for uninsured patients, typically billed monthly.
Services on the Platform
Alpha Medical's publicly listed service categories include:
- Weight management: GLP-1 agonist prescriptions (semaglutide, tirzepatide) plus lifestyle coaching
- Primary care: Chronic disease management, lab orders, referrals
- Mental health: Anxiety and depression medication management
- Sexual and reproductive health: Birth control, STI testing referrals
Prescriber Credentials
Clinicians on the platform are reported to include both physicians (MD/DO) and nurse practitioners (NP). State law governs scope of practice; in states without full practice authority for NPs, physician oversight agreements are required. Alpha Medical does not publish a live roster of its prescribers, which makes independent verification harder than with platforms that list provider profiles.
LegitScript Certification: What It Is and Whether Alpha Medical Has It
LegitScript certification is the clearest third-party signal of compliance for online pharmacies and telehealth operators. The FDA, Google, Facebook, and major payment processors use LegitScript's database to screen platforms before granting advertising accounts or processing payments. A telehealth platform that is LegitScript-certified has agreed to operate lawfully, dispense only FDA-approved medications through licensed pharmacies, and follow applicable prescribing standards.
What LegitScript Actually Checks
LegitScript's telehealth operator certification program, launched in 2021, evaluates:
- Whether prescribers hold valid, unrestricted state licenses
- Whether prescriptions are issued only after a legitimate patient-provider relationship is established
- Whether fulfillment pharmacies are properly licensed in every state they ship to
- Whether advertising claims are truthful and non-deceptive
These checks align directly with the Ryan Haight Online Pharmacy Consumer Protection Act, which requires an in-person evaluation (or a DEA-approved telemedicine exception) before Schedule III-V controlled substances can be prescribed online. The DEA's 2023 proposed rules on telemedicine prescribing of controlled substances reaffirmed these standards.
Alpha Medical's LegitScript Status
As of July 2025, Alpha Medical does not appear in LegitScript's searchable directory of certified telehealth operators or certified online pharmacies. The absence of a listing does not confirm that the platform is operating illegally. Some legitimate telehealth companies have not pursued certification. The absence does mean patients cannot rely on LegitScript as independent verification of Alpha Medical's compliance practices.
For comparison, Hims & Hers, LifeMD, and Noom Med all hold or have held LegitScript telehealth operator certification, making their compliance posture easier to verify publicly.
HealthRX Legitimacy Framework for Evaluating Telehealth Platforms
When LegitScript certification is absent, patients should cross-check five additional signals:
| Signal | Where to Check | Alpha Medical Status | |---|---|---| | State medical board license (prescriber) | State board website | Not centrally published | | State pharmacy board license (fulfillment pharmacy) | NABP e-Profile | Pharmacy partner names not disclosed publicly | | BBB accreditation | bbb.org | Not accredited | | URAC or ACHC telehealth accreditation | urac.org / achc.org | Not found | | FDA MedWatch adverse event reports | fda.gov/safety/medwatch | No specific Alpha Medical entries identified |
BBB Rating and Complaint Analysis
The Better Business Bureau is not a regulatory body, but its complaint database provides a real-world window into patterns of consumer harm that formal enforcement agencies are slower to capture.
Current BBB Profile
Alpha Medical's BBB profile, as last reviewed for this article, shows the company is not BBB accredited. The profile lists multiple complaints in the billing and collections category, with secondary clusters around service issues (prescriptions not processed or delayed) and guarantee/refund disputes.
The BBB assigns letter grades (A+ through F) based on complaint volume relative to business size, time in business, responsiveness, and other factors. Alpha Medical's grade fluctuates; patients should check the live BBB page directly at bbb.org because grades are updated as complaints are resolved or added.
Common Complaint Themes
Reviewing the publicly posted complaint narratives reveals recurring patterns:
- Subscription cancellation difficulty. Patients report being charged after canceling, with customer service response times described as slow.
- Prescription processing delays. Several complaints describe prescriptions not being sent to pharmacy despite payment, causing gaps in GLP-1 medication.
- Refund disputes. Patients who discontinued services report difficulty obtaining refunds for unused subscription periods.
These complaint types are not unique to Alpha Medical. They appear across telehealth subscription companies broadly. The FTC's 2023 "click-to-cancel" rule, finalized under 16 CFR Part 425, requires that cancellation be as easy as enrollment. FTC enforcement of subscription cancellation requirements is active and ongoing.
FDA Compliance and GLP-1 Prescribing
Approved vs. Compounded GLP-1 Products
The FDA has approved semaglutide for weight management under the brand name Wegovy (2.4 mg weekly subcutaneous injection) and for type 2 diabetes as Ozempic (up to 2.0 mg weekly). Tirzepatide is approved for weight management as Zepbound (up to 15 mg weekly) and for type 2 diabetes as Mounjaro. The FDA's approval history for semaglutide is documented in its drug database.
During the semaglutide shortage period (2022 to mid-2024), the FDA placed semaglutide on its drug shortage list, which temporarily permitted 503A and 503B compounding pharmacies to produce compounded semaglutide. The FDA removed semaglutide from the shortage list in October 2024 and gave telehealth platforms a wind-down period to stop dispensing compounded versions.
What This Means for Alpha Medical Patients
If Alpha Medical or its pharmacy partners continued dispensing compounded semaglutide after the FDA's compliance deadline (for most 503A pharmacies, May 22, 2025), that activity would place them outside FDA guidance. Patients who received compounded semaglutide from any telehealth platform should confirm with their prescriber whether the product was FDA-approved or compounded, and from which licensed pharmacy.
Alpha Medical's website does reference both branded and compounded GLP-1 options; the specific pharmacy names and current product sourcing are not disclosed with sufficient detail to allow independent verification of FDA compliance status.
Clinical Efficacy Data for GLP-1 Drugs
The GLP-1 receptor agonists prescribed through platforms like Alpha Medical do have strong clinical trial data behind them:
- In STEP-1 (N=1,961), semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks versus 2.4% with placebo (P<0.001). (Wilding et al., NEJM, 2021)
- In SURMOUNT-1 (N=2,539), tirzepatide 15 mg achieved 20.9% mean weight loss at 72 weeks versus 3.1% with placebo (P<0.001). (Jastreboff et al., NEJM, 2022)
The medications work. The legitimacy question is whether patients receive properly sourced, correctly dosed, FDA-compliant versions.
State Licensing and Prescriber Verification
How to Verify a Telehealth Prescriber's License
Every state medical board maintains a public license verification tool. Before accepting a prescription from any telehealth platform, patients can verify:
- The prescriber's name (found on the prescription or prescription receipt)
- The prescriber's license number and status at the issuing state board
- Whether any disciplinary actions are on record
The Federation of State Medical Boards' DocInfo tool at fsmb.org aggregates license status across 50 states for physicians. Nurse practitioners can be verified through individual state nursing boards.
Alpha Medical does not publish a provider directory with license numbers. This is common among telehealth platforms but means patients must request this information directly.
State-by-State Availability
Alpha Medical lists coverage in most contiguous U.S. States. States with stricter telehealth prescribing laws (such as those requiring synchronous video visits for certain drug classes) may limit what services are available there. Patients in Louisiana, Texas, and a handful of other states have reported service restrictions in online reviews.
The Centers for Medicare and Medicaid Services published updated telehealth coverage requirements for 2025 that affect how Medicare and Medicaid reimburse telehealth visits. CMS telehealth guidance is available through the CMS website.
Patient Reviews: What Real Users Report
Positive Feedback Patterns
Patients who report positive experiences with Alpha Medical tend to cite:
- Insurance acceptance, which reduces out-of-pocket cost substantially compared to cash-pay-only platforms
- Convenient asynchronous messaging for prescription refills
- Quick initial consultation turnaround
Negative Feedback Patterns
The most consistent criticism across Reddit threads, Trustpilot reviews, and BBB complaints involves three areas:
- GLP-1 supply chain gaps. Patients describe prescriptions being written but not filled due to pharmacy stock issues, with limited proactive communication from the platform.
- Billing after cancellation. Post-cancellation charges appear frequently in formal BBB complaints.
- Slow escalation pathways. When problems arise, patients report difficulty reaching a physician (rather than an automated message or support agent) to resolve clinical questions.
These are meaningful concerns for a platform prescribing GLP-1 medications, which require consistent weekly dosing for clinical benefit. A single missed injection week can disrupt titration schedules and patient outcomes.
How Alpha Medical Compares on Key Legitimacy Signals
The table below places Alpha Medical alongside two LegitScript-certified competitors on the same metrics.
| Metric | Alpha Medical | Hims & Hers | LifeMD | |---|---|---|---| | LegitScript certified | No (not listed) | Yes | Yes | | BBB accredited | No | No | No | | Provider directory public | No | Partial | Partial | | Compounded GLP-1 post-shortage | Unclear | Discontinued | Discontinued | | Insurance accepted | Yes | Limited | Limited | | Async prescribing available | Yes | Yes | Yes |
Insurance acceptance is a genuine differentiator for Alpha Medical. For patients whose plans cover GLP-1 medications, the co-pay via insurance can be dramatically lower than cash-pay alternatives.
Red Flags vs. Green Flags: A Practical Checklist
Red Flags to Watch for With Any Telehealth Platform
- No LegitScript certification and no other third-party accreditation
- Pharmacy name and license number not disclosed before purchase
- Subscription cancellation terms buried in fine print
- Compounded semaglutide offered after the FDA's May 2025 deadline without an individualized clinical justification documented in the patient record
- Prescriptions issued without any synchronous or asynchronous clinical intake with a licensed clinician
Green Flags That Increase Confidence
- LegitScript telehealth operator certification
- NABP-accredited pharmacy fulfillment (verify at nabp.pharmacy)
- Clear prescriber name and license number provided on prescription
- Published cancellation policy with a straightforward process
- Clinical intake that includes at least a medical history review and contraindication screening before prescribing GLP-1 drugs
The American Association of Clinical Endocrinology's 2023 obesity management guidelines state: "Pharmacotherapy for obesity should be initiated by a clinician who has assessed the patient's complete medical history, including contraindications to GLP-1 receptor agonists such as personal or family history of medullary thyroid carcinoma or MEN2." (AACE, 2023)
For semaglutide specifically, the FDA-approved prescribing information lists medullary thyroid carcinoma history and MEN2 as absolute contraindications. Full prescribing information is available via FDA accessdata. Any platform that does not screen for these contraindications before prescribing is operating outside approved labeling.
What Patients Should Do Before Using Alpha Medical
Step 1: Confirm Your Specific Prescriber's License
Request the name of the clinician who will manage your care before completing payment. Look them up on your state medical board's website or at fsmb.org.
Step 2: Ask Which Pharmacy Will Fill Your Prescription
Get the pharmacy's name. Then verify its NABP accreditation status. If a platform refuses to disclose the pharmacy, that is a meaningful warning sign.
Step 3: Read the Cancellation Policy Before Subscribing
The FTC's click-to-cancel rule (16 CFR Part 425, effective January 2024) requires simple cancellation mechanisms. If the cancellation process is not as easy as the sign-up process, you can file a complaint at ftc.gov/complaint.
Step 4: Clarify Whether Any GLP-1 Product Is FDA-Approved or Compounded
Ask directly: "Is this brand-name Wegovy or Zepbound, or is this a compounded product?" If compounded, ask from which 503A or 503B pharmacy, and whether that pharmacy is registered with the FDA. FDA-registered outsourcing facilities (503B) are listed publicly.
Step 5: File a Complaint If Something Goes Wrong
- FTC: reportfraud.ftc.gov for billing and subscription issues
- FDA MedWatch: fda.gov/safety/medwatch for adverse drug reactions or suspected substandard compounded products
- State medical board: For prescriber conduct concerns
- BBB: bbb.org/file-a-complaint for business practice issues
Frequently asked questions
›Is Alpha Medical legit?
›Does Alpha Medical have LegitScript certification?
›What GLP-1 medications does Alpha Medical prescribe?
›What complaints do patients have about Alpha Medical?
›Does Alpha Medical accept insurance?
›How do I verify my Alpha Medical prescriber's license?
›Is compounded semaglutide from Alpha Medical safe?
›How do I cancel my Alpha Medical subscription?
›Does Alpha Medical use NABP-accredited pharmacies?
›What is the difference between URAC and LegitScript accreditation for telehealth?
›How does Alpha Medical compare to competitors like Hims and Ro?
References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. https://www.nejm.org/doi/10.1056/NEJMoa2206038
- FDA. Drug Shortage: Semaglutide injection. Updated October 2024. https://www.fda.gov/drugs/drug-shortages/fdas-actions-compounded-versions-semaglutide-products
- FDA. Wegovy (semaglutide) prescribing information. 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
- FDA. Drugs@FDA: semaglutide approvals. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- LegitScript. Telehealth operator certification program. https://www.legitscript.com/what-we-do/certification/
- DEA. DEA proposes new telemedicine rules. February 2023. https://www.dea.gov/press-releases/2023/02/24/dea-proposes-new-telemedicine-rules
- FTC. Federal Trade Commission announces final click-to-cancel rule. October 2023. https://www.ftc.gov/news-events/news/press-releases/2023/10/federal-trade-commission-announces-final-click-cancel-rule
- American Association of Clinical Endocrinology. Clinical practice guidelines for obesity management. 2023. https://www.endocrine.org/clinical-practice-guidelines
- CMS. Medicare telehealth services. 2025. https://www.cms.gov/medicare/coverage/telehealth
- FDA. Registered outsourcing facilities (503B). https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- FDA MedWatch: The FDA Safety Information and Adverse Event Reporting Program. https://www.fda.gov/safety/medwatch
- Federation of State Medical Boards. DocInfo physician data. https://www.fsmb.org/docinfo/
- NABP. Pharmacy verification. https://nabp.pharmacy